ACTON, Mass. --(BUSINESS WIRE)--Feb. 13, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced a voluntary Medical Device Correction for all Omnipod DASH™ Personal
Does this mean you will replace all the current Omnipod DASH™ PDMs in the field? A software update is being developed to provide a solution for this issue and is expected to be available starting March 2020. We will provide new PDMs containing the software update to all Omnipod DASH™ users and we
ACTON, Mass. --(BUSINESS WIRE)--Jan. 6, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full
ACTON, Mass. --(BUSINESS WIRE)--Dec. 20, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 38 th Annual J.P.
LONDON --(BUSINESS WIRE)--Dec. 18, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the launch of the new Omnipod DASH™ Insulin Management System
ACTON, Mass. --(BUSINESS WIRE)--Nov. 7, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The 2019 Stephens
ACTON, Mass. --(BUSINESS WIRE)--Nov. 5, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for the three months ended September
Insulet Further Demonstrating Commitment to Innovation and Patient Choice ACTON, Mass. --(BUSINESS WIRE)--Oct. 25, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today
ACTON, Mass. --(BUSINESS WIRE)--Sep. 30, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2019 on
ACTON, Mass. --(BUSINESS WIRE)--Sep. 23, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced it has received clearance from the U.S.
ACTON, Mass. --(BUSINESS WIRE)--Sep. 4, 2019-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), has priced a private placement of $700 million aggregate principal amount of
ACTON, Mass. --(BUSINESS WIRE)--Sep. 3, 2019-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced its intention to offer, subject to market and other conditions,
Mobile Apps Allow for Convenient and Discreet Remote Viewing of a User’s or Loved One’s Data ACTON, Mass. --(BUSINESS WIRE)--Aug. 9, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System
ACTON, Mass. --(BUSINESS WIRE)--Aug. 5, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for the three months ended June 30,
ACTON, Mass. --(BUSINESS WIRE)--Jul. 31, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Jim Hollingshead , Ph.D., has been appointed to the
